Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer

S Senan, JVS De Koste, M Samson, H Tankink… - Radiotherapy and …, 1999 - Elsevier
Background: A protocol for the contouring of target volumes in lung cancer was
implemented. Subsequently, a study was performed in order to determine the intra and inter …

Quantification of tumor volume changes during radiotherapy for non–small-cell lung cancer

J Fox, E Ford, K Redmond, J Zhou, J Wong… - International Journal of …, 2009 - Elsevier
PURPOSE: Dose escalation for lung cancer is limited by normal tissue toxicity. We
evaluated sequential computed tomography (CT) scans to assess the possibility of …

[HTML][HTML] Anatomic change over the course of treatment for non–small cell lung cancer patients and its impact on intensity-modulated radiation therapy and passive …

M Chen, J Yang, Z Liao, J Chen, C Xu, X He… - Radiation …, 2020 - Springer
Purpose To quantify tumor anatomic change of non-small cell lung cancer (NSCLC) patients
given passive-scattering proton therapy (PSPT) and intensity-modulated radiation therapy …

Radiation dose prescription for non–small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial

A van Baardwijk, G Bosmans, SM Bentzen… - International Journal of …, 2008 - Elsevier
PURPOSE: Local tumor recurrence remains a major problem in patients with inoperable non–
small-cell lung cancer undergoing radiotherapy. We investigated the theoretical gain in the …

Intrafraction motion in stereotactic body radiation therapy for non-small cell lung cancer: intensity modulated radiation therapy versus volumetric modulated arc therapy

MMG Rossi, HMU Peulen, JSA Belderbos… - International Journal of …, 2016 - Elsevier
Purpose Stereotactic body radiation therapy (SBRT) for early-stage inoperable non-small
cell lung cancer (NSCLC) patients delivers high doses that require high-precision treatment …

Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?

P Berkovic, L Paelinck, Y Lievens, A Gulyban… - Acta …, 2015 - Taylor & Francis
Background. Adaptive radiotherapy (ART) could be a tool to reduce toxicity and to facilitate
dose escalation in stage III NSCLC. Our aim was to identify the most appropriate time and …

Reduction of normal lung irradiation in locally advanced non–small-cell lung cancer patients, using ventilation images for functional avoidance

BP Yaremko, TM Guerrero, J Noyola-Martinez… - International Journal of …, 2007 - Elsevier
Purpose: To investigate the ability of four-dimensional computed tomography (4D-CT)–
derived ventilation images to identify regions of highly functional lung for avoidance in …

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome

T Kataria, D Gupta, SS Bisht… - The British journal of …, 2014 - academic.oup.com
Objective: Anatomical changes during radiotherapy (RT) might introduce discrepancies
between planned and delivered doses. This study evaluates the need for adaptive treatment …

A study on the influence of breathing phases in intensity-modulated radiotherapy of lung tumours using four-dimensional CT

WC Wu, CL Chan, YW Wong… - The British Journal of …, 2010 - academic.oup.com
During gated intensity-modulated radiotherapy (IMRT) treatment for patients with inoperable
non-small cell lung cancer (NSCLC), the end-expiration (EE) phase of respiratory is more …

[HTML][HTML] Intensity-modulated radiotherapy for lung cancer: current status and future developments

C Chan, S Lang, C Rowbottom, M Guckenberger… - Journal of Thoracic …, 2014 - Elsevier
Radiotherapy plays an important role in the management of lung cancer, with over 50% of
patients receiving this modality at some point during their treatment. Intensity-modulated …